Acute revascularization in ST-segment-elevation myocardial infarction

Area of Science:

• Cardiology
• Interventional Cardiology
• Acute Coronary Syndromes

Background:

• ST-segment-elevation myocardial infarction (STEMI) management has evolved since 2011/2012 guideline updates.
• Significant new studies have emerged, impacting current treatment strategies.
• Ongoing debates exist regarding controversial approaches in STEMI care.

Purpose of the Study:

• To comprehensively review novel findings in STEMI revascularization therapy and management.
• To highlight evidence-based advancements in pharmacological and mechanical treatments for STEMI.
• To discuss recent experiences with biodegradable scaffold stents in STEMI treatment.

Main Methods:

• Literature review of recent studies and guideline updates.
• Synthesis of evidence-based advancements in STEMI treatment.
• Discussion of controversial topics and novel therapeutic strategies.

Main Results:

• Recent studies have introduced significant changes to STEMI management protocols.
• Pharmacological and mechanical revascularization techniques continue to advance.
• Biodegradable scaffold stents represent a novel treatment option with emerging data.

Conclusions:

• Current STEMI management incorporates updated evidence and evolving therapeutic options.
• The field necessitates ongoing evaluation of new technologies like biodegradable stents.
• Understanding controversial approaches is crucial for informed clinical decision-making in STEMI.